Immune response induced by Moderna Covid-19 vaccine in first phase

In a first phase study, a possible Covid-19 vaccine developed by the biotech company Moderna together with the National Institutes of Health has induced immune responses in all of the patients. While the vaccine had mild side effects such as chills, headache or muscle pain, it is the first vaccine candidate from the United States to be published in a peer-reviewed medical journal.

A large phase three trial will be started this month after which, depending on the results, regulators will decide of it'll made available to the public.